Lonafarnib Boosted With Ritonavir With and Without Peginterferon Alfa-2a (PEG IFN-a) in HDV (LOWR-2)

NCT02430194 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis D Infection

Interventions

DRUG: lonafarnib
DRUG: ritonavir
DRUG: Pegylated interferon-alfa-2a

Sponsor

Eiger BioPharmaceuticals

Collaborators

[object Object]